Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

NCT00105547 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

NCT04187547 ·Status: WITHDRAWN ·Phase: PHASE3

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease

NCT01689233 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease

NCT03625401 ·Status: UNKNOWN ·Phase: PHASE2

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

NCT00574132 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

NCT00257673 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

NCT02626572 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study of NE3107 in Probable Alzheimer's Disease

NCT04669028 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study for Safety and Tolerability of AL002.

NCT03635047 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease

NCT01482013 ·Status: TERMINATED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease

NCT03186989 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

NCT00006187 ·Status: TERMINATED ·Phase: PHASE3

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

NCT00722046 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

NCT04592874 ·Status: COMPLETED ·Phase: PHASE2

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

NCT00945672 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

NCT03790982 ·Status: UNKNOWN ·Phase: PHASE2

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

NCT00041678 ·Status: COMPLETED ·Phase: PHASE3

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

NCT05531526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

NCT03462121 ·Status: COMPLETED ·Phase: PHASE2

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

NCT03131453 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

NCT02547818 ·Status: COMPLETED ·Phase: PHASE3

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

NCT03806478 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

NCT01689246 ·Status: COMPLETED ·Phase: PHASE3

Tricaprilin in Mild to Moderate Alzheimer's Disease

NCT00142805 ·Status: COMPLETED ·Phase: PHASE2